Loren Data's SAM Daily™

fbodaily.com
Home Today's SAM Search Archives Numbered Notes CBD Archives Subscribe
FBO DAILY ISSUE OF JUNE 25, 2011 FBO #3500
SOLICITATION NOTICE

66 -- Carl Zeiss Axio Observer Microscope

Notice Date
6/23/2011
 
Notice Type
Presolicitation
 
NAICS
333314 — Optical Instrument and Lens Manufacturing
 
Contracting Office
Department of Health and Human Services, National Institutes of Health, National Cancer Institute, Office of Acquisitions, 6120 Executive Blvd., EPS Suite 600, Rockville, Maryland, 20852
 
ZIP Code
20852
 
Solicitation Number
NCI-110083-MD
 
Archive Date
7/22/2011
 
Point of Contact
Miguel Diaz, Phone: (301) 435-3817, Caren N Rasmussen, Phone: (301) 402-4509
 
E-Mail Address
miguel.diaz@nih.gov, cr214i@nih.gov
(miguel.diaz@nih.gov, cr214i@nih.gov)
 
Small Business Set-Aside
N/A
 
Description
Contracting Office Address Department of Health and Human Services, National Institutes of Health, National Cancer Institute, Office of Acquisitions, 6120 Executive Boulevard, EPS Suite 600, Room 6079, Rockville, MD 20852, UNITED STATES. Description The National Cancer Institute (NCI), Center for Cancer Research (CCR), Laboratory of Receptor Biology and Gene Expression plans to procure on a sole source basis the brand name Carl Zeiss Axio Observer from Carl Zeiss MicroImaging of One Zeiss Dr. Thornwood, NY 10594. This acquisition will be processed under FAR Part 12 - Acquisition for Commercial Items and will be made pursuant to the authority in FAR 13.106-1(b)(2) and 13.501-(a)(1) using simplified acquisition procedures for commercial acquisitions. The North American Industry Classification System Code is 333314 and the business size standard is 500employees. Only one award will be made as a result of this solicitation. This will be awarded as a firm fixed price type contract. The National Cancer Institute (NCI), Center for Cancer Research, Laboratory of Receptor Biology and Gene Expression, conducts an integrated research program designed to elucidate the cellular and tissue changes associated with specific stages of carcinogenesis, to detect genetic modifiers fundamental to cancer susceptibility and progression, to define the molecular mechanisms involved in the pathogenesis of major human cancers, and to develop rational approaches for cancer prevention and treatment. The purpose of this acquisition is to acquire a microscope that will be a part of a larger optical system in the Systems Biology of Gene Expression Section in the Laboratory of Receptor Biology and Gene Expression designed to interrogate gene expression at the single molecule level in living cells. As such, the microscope must be sensitive enough to detect single photons from biological samples, necessitating optics and objectives with high efficiency in the UV, visible, and infrared regions of the electromagnetic spectrum. It must be mechanically stable for long time-lapse measurements, adaptable to multiple sources of excitation, including laser excitation, mercury arc-lamp excitation, metal halide excitation, must not exceed the 4' x 4' size limitation of the workspace, and be compatible with the existing microscopes in the NCI Microscopy Core Facility. The following salient characteristics apply to the Zeiss Axio Observer Inverted Light Microscope: • 63x c-Apo Objective with water immersion. • Oil with refractive index of water included. • Focus Stabilization is fully integrated into hardware allowing touch control from a docking station. • Hardware Docking Station which can control microscope remotely as well as provide a comfortable Focus drive remotely. Unit is able to sit remotely off of the Microscope table for vibration considerations and be positioned near the computer workstation. • Transmitted and Fluorescent Light paths include Halogen and metal halide illumination, respectively, with fiber optic delivery to the microscope for the fluorescence illumination. • Fully programmable ergonomic button control of all motorized features near the focus knobs of the stand for easy control. • Z focus drive is capable of 9.9mm travel range with a 10nm step size. • Integrated Contrast Manager to preset all light and microscope conditions for visual use. • High Pressure Casting with Large mechanical Footprint for outstanding mechanical and thermal isolation for all external mounted accessories as well as providing ultra stability from external influences like fluctuating room temperature is required. • Ability to integrate with a structured illumination device in the reflected light path to do wide field structural optical sectioning to eliminate background fluorescence. • Access to the infinity space of the reflected light path for integration of external laser - separate from the back port of the microscope. • Fluorescence Beam Path Apo chromatically corrected. • 6x reflector turret with 200ms switching time. • Reflector turret capable of laser integration. • Easy push and click replaceable filter cubes. • Capable of fully integrated Incubation controllable via the touchpad. • All hardware fully integrated with Micromanager Software. The Zeiss Axio Observer Microscope is the only known device to possess the unique characteristics essential to the National Cancer Institute (NCI), Center for Cancer Research (CCR), Laboratory of Receptor Biology and Gene Expression's ongoing clinical and research operations. Carl Zeiss MicroImaging is the manufacturer and distributor of the Zeiss Axio Observer and only known source. This is not a solicitation for competitive quotations. However, if any interested party believes they can meet the above requirement, they may submit a statement of capabilities. All information furnished must be in writing and must contain sufficient detail to allow the NCI to determine if it can meet the above unique specifications described herein. An original and one copy of the capability statement must be received in the NCI Office of Acquisitions on or before 11:00 AM EST on July 07, 2011. No electronic capability statements will be accepted (i.e. email or fax); an original and one copy must be sent to the NCI Office of Acquisitions to the address stated above. All questions must be in writing and can be faxed (301) 402-4513 or emailed to Miguel Diaz, Contract Specialist at miguel.diaz@mail.nih.gov. A determination by the Government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement. In order to receive an award, contractors must have valid registration and certification in the Central Contractor Registration (CCR) www.ccr.gov and the Online Representations and Certifications Applications (ORCA), http://orca.bpn.gov. No collect calls will be accepted. Please reference solicitation number NCI-110083-MD on all correspondences
 
Web Link
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/NIH/RCB/NCI-110083-MD/listing.html)
 
Place of Performance
Address: NCI, CCR, Laboratory of Receptor Biology and Gene Expression, 41 Center Dr., Building 41, B201, Bethesda, Maryland, 20892, United States
Zip Code: 20892
 
Record
SN02481150-W 20110625/110623235652-a06550395e86a4b081fb82da5f309dcb (fbodaily.com)
 
Source
FedBizOpps Link to This Notice
(may not be valid after Archive Date)

FSG Index  |  This Issue's Index  |  Today's FBO Daily Index Page |
ECGrid: EDI VAN Interconnect ECGridOS: EDI Web Services Interconnect API Government Data Publications CBDDisk Subscribers
 Privacy Policy  Jenny in Wanderland!  © 1994-2024, Loren Data Corp.